| 词条 | Sandra M. Swain |
| 释义 |
| name = Sandra M. Swain | image = Cropping of Dr. Sandra Swain at ASCO 2013 Annual Meeting.jpg|image_upright=1.2| caption = Swain at ASCO 2013 Annual Meeting in Chicago, IL | birth_date = {{birth year and age |1954}} | residence = Bethesda, Maryland | education = University of North Carolina at Chapel Hill (B.A.) University of Florida (M.D.) | occupation = Oncologist, clinical breast cancer researcher | years_active = 1980–present }}Sandra M. Swain is an American oncologist, breast cancer specialist and clinical translational researcher.[1] She is currently a professor of Medicine at the Georgetown University School of Medicine and the Associate Dean for Research Development at Georgetown University Medical Center (GUMC) and MedStar Health [2] as well as an adjunct professor of Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of Health Sciences.[3] She is also a past President of the American Society of Clinical Oncology (ASCO), serving from 2012 through 2013.[1][2][3][4] The focus of Sandra's research includes clinical trials and translational research in metastatic and inflammatory breast cancer, adjuvant treatment of breast cancer, the treatments of metastatic HER2+ breast cancer, cardiotoxicity, as well as health care disparities.[1],[2],[3] She has authored more than 275 articles on her research in multiple medical journals, including the New England Journal of Medicine (NEJM) and the Journal of Clinical Oncology (JCO).[5] In addition, she has been interviewed in The New York Times[6] and the Wall Street Journal,[7] as well as on NPR's Weekend Edition Sunday[8] and the PBS NewsHour.[9] CareerAfter completing her fellowship at the NCI and running clinical trials for two years under Dr. Marc Lippman and alongside Dr. Robert Dickson, Swain founded the breast cancer program at Georgetown University'sLombardi Comprehensive Cancer Center (LCCC) in 1988.[10] This program is now known as the Betty Lou Ourisman Breast Health Center. She returned to the NCI in 1995 and, by 1999, became a Tenured Principal Investigator and the Deputy Chief of the Medicine Branch within the Division of Clinical Sciences, ultimately becoming Chief of the Cancer Therapeutics Branch at the Center for Cancer Research. In 2007, after a 12-year stint at the NCI, Swain accepted the position of Medical Director at the Washington Cancer Institute (WCI) at the MedStar Washington Hospital Center (MWHC).[1],[11] At this time, Swain had a growing interest in healthcare inequality and a desire to dedicate her efforts to the underserved African American community in Washington, D.C. During her time as medical director at the WCI, she studied the causes of increased breast cancer mortality observed in African American women.[12][13] In 2016, after almost a decade at the WCI, Swain was appointed as the Associate Dean for Research Development to pursue research collaborations, business development, and funding opportunities between Georgetown University and industry, medical/scientific associations, governmental agencies, and other entities at all levels.[2] Over the past 35 years, Swain has held advisory and leadership positions with professional oncology societies and organizations. These include Susan G. Komen for the Cure, the American Society of Clinical Oncology, the Conquer Cancer Foundation, the National Surgical Adjuvant Breast and Bowel Project (NSABP), and the National Accreditation Program for Breast Centers.[14] Swain is a national past-President of the American Society of Clinical Oncology (ASCO) serving from 2012 through 2013.[1],[2],[3],[4] She currently serves as the Treasurer for ASCO's Conquer Cancer Foundation.[15] Most recently, Swain was invited to join the Scientific Advisory Board for Inivata Ltd.[16] Bibliography
| author = Sandra M. Swain, Jose Baselga, Sung-Bae Kim, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Sarah Heeson, Emma Clark, Graham Ross, Mark C. Benyunes & Javier Cortes | title = Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer | journal = The New England Journal of Medicine | volume = 372 | issue = 8 | pages = 724–734 | year = 2015 | doi = 10.1056/NEJMoa1413513 | pmid = 25693012 | pmc=5584549 }}
| author = Jose Baselga, Javier Cortes, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Young-Hyuck Im, Laslo Roman, Jose Luiz Pedrini, Tadeusz Pienkowski, Adam Knott, Emma Clark, Mark C. Benyunes, Graham Ross & Sandra M. Swain | title = Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer | journal = The New England Journal of Medicine | volume = 366 | issue = 2 | pages = 109–119 | year = 2012 | doi = 10.1056/NEJMoa1113216 | pmid = 22149875 }}
| author = Sandra M. Swain, Jong-Hyeon Jeong, Charles E. Jr Geyer, Joseph P. Costantino, Eduardo R. Pajon, Louis Fehrenbacher, James N. Atkins, Jonathan Polikoff, Victor G. Vogel, John K. Erban, Priya Rastogi, Robert B. Livingston, Edith A. Perez, Eleftherios P. Mamounas, Stephanie R. Land, Patricia A. Ganz & Norman Wolmark | title = Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer | journal = The New England Journal of Medicine | volume = 362 | issue = 22 | pages = 2053–2065 | year = 2010 | doi = 10.1056/NEJMoa0909638 | pmid = 20519679 | pmc=2935316 }}
| author = Chia C. Portera, Janice M. Walshe, Douglas R. Rosing, Neelima Denduluri, Arlene W. Berman, Ujala Vatas, Margarita Velarde, Catherine K. Chow, Seth M. Steinberg, Diana Nguyen, Sherry X. Yang & Sandra M. Swain | title = Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer | journal = Clinical Cancer Research | volume = 14 | issue = 9 | pages = 2710–2716 | year = 2008 | doi = 10.1158/1078-0432.CCR-07-4636 | pmid = 18451236 | pmc=4406095 }}
| author = Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Jr Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann M. Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela M. Klein, James N. Ingle & Norman Wolmark | title = Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer | journal = The New England Journal of Medicine | volume = 353 | issue = 16 | pages = 1673–1684 | year = 2005 | doi = 10.1056/NEJMoa052122 | pmid = 16236738 }}
| author = Sandra M. Swain, Fredrick S. Whaley & Michael S. Ewer | title = Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials | journal = Cancer | volume = 97 | issue = 11 | pages = 2869–2879 | year = 2003 | doi = 10.1002/cncr.11407 | pmid = 12767102 }}
| author = Sandra M. Swain, F. S. Whaley, M. C. Gerber, S. Weisberg, M. York, D. Spicer, S. E. Jones, S. Wadler, A. Desai, C. Vogel, J. Speyer, A. Mittelman, S. Reddy, K. Pendergrass, E. Velez-Garcia, M. S. Ewer, J. R. Bianchine & R. A. Gams | title = Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer | journal = Journal of Clinical Oncology | volume = 15 | issue = 4 | pages = 1318–1332 | year = 1997 | pmid = 9193323 | doi=10.1200/jco.1997.15.4.1318 }}
| author = S. M. Swain, F. S. Whaley, M. C. Gerber, M. S. Ewer, J. R. Bianchine & R. A. Gams | title = Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy | journal = Journal of Clinical Oncology | volume = 15 | issue = 4 | pages = 1333–1340 | year = 1997 | pmid = 9193324 | doi=10.1200/jco.1997.15.4.1333 }} References1. ^1 2 3 4 {{cite web | url=https://www.bcrfcure.org/researchers/sandra-m-swain| title=Meet Our Researchers: Sandra Swain | author=Breast Cancer Research Foundation | author-link=The Breast Cancer Research Foundation | access-date=October 1, 2016}} {{authority control}}{{DEFAULTSORT:Swain, Sandra M.}}2. ^1 2 3 4 {{cite press release | url=https://gumc.georgetown.edu/news/swain| title=Sandra Swain, MD appointed Associate Dean for Research Development| first=Edward B. | last=Healton | date=April 11, 2016| publisher=Georgetown University | access-date=October 1, 2016}} 3. ^1 2 3 {{cite press release | url=https://gumc.georgetown.edu/news/georgetown-lombardi-breast-cancer| title=Georgetown Lombardi Breast Cancer Expert to Lead ASCO| first=Karen | last=Mallet| date=June 18, 2012| publisher=Georgetown University| location=Washington, D.C. | access-date=October 1, 2016}} 4. ^1 {{cite web | url=http://www.asco.org/about-asco/asco-overview/society-history/past-presidents | title=Past Presidents | author=American Society of Clinical Oncology | author-link=American Society of Clinical Oncology | access-date=October 1, 2016}} 5. ^{{cite web| url=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Swain+SM%5Bau%5D&dispmax=50| author= National Center for Biotechnology Information | title=PubMed Author Search | access-date=October 2, 2016}} 6. ^{{cite web | url=https://www.nytimes.com/2014/09/29/business/roche-breast-cancer-drug-appears-to-greatly-extend-patients-lives.html?_r=0| title=Roche Breast Cancer Drug Perjeta Appears to Greatly Extend Patients' Lives | author=Andrew Pollack | date=September 28, 2014 | website=The New York Times | access-date=October 2, 2016}} 7. ^{{cite web | url=https://www.wsj.com/articles/SB10001424127887323466204578384732911187000 | title='Big Data' for Cancer Care: Vast Storehouse of Patient Records Will Let Doctors Search for Effective Treatment | author=Ron Winslow | date=March 26, 2013 | website=The Wall Street Journal | access-date=October 2, 2016}} 8. ^{{cite episode | title=Sunday, March 13, 2013 | transcript=Harnessing Big Data to Combat Cancer | transcript-url=https://www.npr.org/2013/03/31/175829144/harnessing-big-data-to-combat-cancer| series=Weekend Edition Sunday | network=NPR | air-date=March 31, 2013}} 9. ^{{cite news | last=Kane | first=Jason | date=December 25, 2012 | title=Commentary: Why Mammograms Are So Crucial | url=http://www.pbs.org/newshour/rundown/commentary-why-mammograms-are-important/ | newspaper=PBS NewsHour | location=Washington, D.C. | access-date=October 2, 2016}} 10. ^{{cite web| url=http://www.bizjournals.com/washington/news/2016/09/09/sandra-swain.html| title=Women Who Mean Business: Sandra Swain| author=Tina Reed| date=September 9, 2016| website=Washington Business Journal| access-date=October 1, 2016}} 11. ^{{cite web| url=http://www.ascopost.com/issues/june-15-2012-supplement/new-asco-president-reflects-on-value-of-mentorship-and-addressing-health-care-disparities/| title=New ASCO President Reflect on Value of Mentorship and Addressing Health-care Disparities| author=Ronald Piana | date=June 15, 2012| website=The ASCO Post| access-date=October 1, 2016}} 12. ^{{cite journal | last1 =Banda | first1 =Deliya R | last2 = Libin | first2 = Alexander V | last3= Wang | first3= Hong | last4= Swain | first4= Sandra M | title =A Pilot Study of a Culturally Targeted Video Intervention to Increase Participation of African American Patients in Cancer Clinical Trials | journal =The Oncologist | volume =17 | pages = 708–714 | date = 2012 | url =http://theoncologist.alphamedpress.org/content/17/5/708 | access-date = October 20, 2017 | doi=10.1634/theoncologist.2012-0454| pmc=3360910 }} 13. ^{{cite journal | last1 =Robinson | first1 =Brandi N | last2 = Newman | first2 = Antoinette F | last3= Tefera | first3= Eshetu | last4= Herbolsheimer | first4= Pia |last5=Nunes |first5=Raquel |last6=Gallagher |first6=Chris | last7=Randolph-Jackson |first7=Pamela |last8= Omogbehin |first8= Adedamola | last9= Dilawari |first9=Asma | last10=Pohlmann | first10=Paula R| last11=Mohebtash | first11=Mahsa | last12=Lee | first12= Young | last13= Ottaviano | first13= Yvonne | last14= Mohapatra | first14=Avani | last15=Lynce | first15=Filipa | last16=Brown | first16=Richard | last17=Mete | first17=Mihriye | last18=Swain| first18=Sandra M | title =Video intervention increases participation of black breast cancer patients in therapeutic trials | journal =npj Breast Cancer | volume =3 | pages = Article 36 | date = 2017 | url =https://www.nature.com/articles/s41523-017-0039-1 | access-date = October 20, 2017 | doi=10.1038/s41523-017-0039-1}} 14. ^{{ cite web | url=http://www.medstarhealth.org/mhri/physician-investigator/sandra-swain/#q={} | author=MedStar Health Research Institute | title=Principal Investigators | author-link=MedStar Health#MedStar Health Research Institute | access-date=October 2, 2016}} 15. ^{{cite web| url=https://www.conquercancerfoundation.org/about/board-of-directors | author=Conquer Cancer Foundation| title=Board of Directors | author-link=American Society of Clinical Oncology#Conquer Cancer Foundation | access-date=October 3, 2016}} 16. ^{{cite press release | url=https://www.inivata.com/inivata-announces-world-leading-scientific-advisory-board/| title=Inivata Announces World-Leading SAB | last=Inivata Ltd. | date=October 26, 2017| access-date=October 27, 2017}} 13 : Scientists from Washington, D.C.|American oncologists|American women physicians|American women scientists|Living people|Breast cancer|Cancer researchers|1954 births|American medical researchers|Georgetown University Medical Center faculty|Uniformed Services University of the Health Sciences faculty|University of North Carolina at Chapel Hill alumni|University of Florida College of Medicine alumni |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。